دورية أكاديمية
E-Cigarette Use Among persons With Diagnosed HIV in the U.S.
| العنوان: | E-Cigarette Use Among persons With Diagnosed HIV in the U.S. |
|---|---|
| المؤلفون: | Thorne SL; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Caraballo RS; Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia., Tie Y; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Harris NS; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Shouse RL; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Brooks JT; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. |
| المصدر: | AJPM focus [AJPM Focus] 2023 Mar; Vol. 2 (1). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Inc. on behalf of the American Journal of Preventive Medicine Board of Governors Country of Publication: England NLM ID: 9918487585606676 Publication Model: Print Cited Medium: Internet ISSN: 2773-0654 (Electronic) Linking ISSN: 27730654 NLM ISO Abbreviation: AJPM Focus Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [New York] : Elsevier Inc. on behalf of the American Journal of Preventive Medicine Board of Governors, [2022]- |
| مستخلص: | Introduction: E-cigarettes emerged in the U.S. market in the late 2000s. In 2017, E-cigarette use among U.S. adults was 2.8%, with higher use among some population groups. Limited studies have assessed E-cigarette use among persons with diagnosed HIV. The purpose of this study is to describe the national prevalence estimates of E-cigarette use among persons with diagnosed HIV by selected sociodemographic, behavioral, and clinical characteristics. Methods: Data were collected between June 2018 and May 2019 as part of the Medical Monitoring Project, an annual cross-sectional survey that produces nationally representative estimates of behavioral and clinical characteristics of persons with diagnosed HIV in the U.S. Statistically significant differences ( p <0.05) were determined using chi-square tests. Data were analyzed in 2021. Results: Among persons with diagnosed HIV, 5.9% reported currently using E-cigarettes, 27.1% had ever used them but were not using them currently, and 72.9% had never used them. Current use of E-cigarettes was highest among persons with diagnosed HIV who currently smoke conventional cigarettes (11.1%), those with major depression (10.8%), those aged 25-34 years (10.5%), those who reported injectable and noninjectable drug use in the past 12 months (9.7%), those diagnosed <5 years ago (9.5%), those who self-reported sexual orientation as other (9.2%), and non-Hispanic White people (8.4%). Conclusions: Overall, findings suggest that a greater proportion of persons with diagnosed HIV used E-cigarettes than the overall U.S. adult population and that higher rates were observed among certain subgroups, including those who currently smoke cigarettes. E-cigarette use among persons with diagnosed HIV warrants continued attention because of its potential impact on HIV-related morbidity and mortality. Competing Interests: DECLARATIONS OF INTEREST None. |
| References: | Int J Public Health. 2016 Mar;61(2):189-97. (PMID: 26521213) Nicotine Tob Res. 2016 Oct;18(10):1926-1936. (PMID: 27113014) MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164. (PMID: 30763302) PLoS One. 2020 Feb 21;15(2):e0229345. (PMID: 32084211) J Addict Behav Ther Rehabil. 2013 Sep 1;2(3):1000112. (PMID: 24839610) AIDS Care. 2017 Oct;29(10):1309-1314. (PMID: 28535687) JAMA Netw Open. 2020 Oct 1;3(10):e2020694. (PMID: 33048127) Am J Respir Crit Care Med. 2018 Feb 15;197(4):492-501. (PMID: 29053025) PLoS One. 2015 Mar 30;10(3):e0122544. (PMID: 25822251) Am J Med. 2019 Aug;132(8):949-954.e2. (PMID: 30853474) Am J Prev Med. 2019 May;56(5):655-663. (PMID: 30885517) Annu Rev Public Health. 2018 Apr 1;39:215-235. (PMID: 29323609) Prev Med. 2018 Jun;111:231-234. (PMID: 29550303) PLoS One. 2014 Mar 24;9(3):e92842. (PMID: 24663122) JAMA. 2018 May 15;319(19):2039-2041. (PMID: 29800201) N Engl J Med. 2019 Feb 14;380(7):629-637. (PMID: 30699054) Nicotine Tob Res. 2009 Jan;11(1):12-24. (PMID: 19246437) J Am Coll Cardiol. 2019 Dec 24;74(25):3112-3120. (PMID: 31740017) Lancet Respir Med. 2016 Feb;4(2):116-28. (PMID: 26776875) AIDS. 2015 Jan 14;29(2):221-9. (PMID: 25426809) |
| معلومات مُعتمدة: | CC999999 United States ImCDC Intramural CDC HHS |
| تواريخ الأحداث: | Date Created: 20230519 Latest Revision: 20230522 |
| رمز التحديث: | 20230522 |
| مُعرف محوري في PubMed: | PMC10193385 |
| DOI: | 10.1016/j.focus.2022.100056 |
| PMID: | 37206980 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2773-0654 |
|---|---|
| DOI: | 10.1016/j.focus.2022.100056 |